Besides FLCN-deficient cell line UOK257, a cell line derived from a BHD patient’s kidney cancer [29], we also employed a RCC cell line, ACHN, with known FLCN expression and its FLCN expression could be effectively suppressed with siRNA. The gene discussed is FLCN; the disease is renal cell carcinoma.